US Home Diagnostics for Urinary Tract Infection Market Forecast to 2027 - COVID-19 Impact and Country Analysis By Form Type and Distribution Channel

The US home diagnostics for urinary tract infection market is expected to reach US$ 444.91 million by 2027 from US$ 267.44 million in 2019; it is expected to grow at a CAGR of 6.7% from 2020 to 2027.

The growth of the market is attributed to the key factors such as the growing UTI prevalence and increasing geriatric population. However, inaccuracy in the results of home UTI screening tests is the major factor hindering its market.

Advancements in the global healthcare sector and increasing emphasis on self care as well as preventive care lead to the emergence of home-based diagnostics. The medical device manufacturers focus on the implementation of new designs and prototypes to offer significant care to patients at home. Home diagnostics confer improved patient care and experience and superior patient convenience, and incur lower cost. Moreover, the introduction of advanced diagnostics products for UTI detection is also projected to increase the adoption of home diagnostics products in the coming years. Further, the increasing emphasis of government authorities to encourage home care provides significant opportunities for the growth of the market players. As per the American Urological Association, November is Bladder Health Awareness Month that serves as a reminder to Americans to gain the knowledge about common bladder health conditions and proactively take initiatives to take care of bladder health. National Health Observance, the Urology Care Foundation sponsored by the US Department of Health and Human Services, is the world's leading nonprofit urological health foundation.

Based on form type, the US home diagnostics for urinary tract infection market is segmented into dipsticks, cups, dipslides, cassettes, and others. In 2019, the dipsticks segment held the largest share of the market and is anticipated to register the highest CAGR during the forecast period. Based on distribution channel, the US home diagnostics for urinary tract infection market is segmented into retail pharmacies and drug stores, supermarkets/hypermarkets, and online pharmacies. The retail pharmacies and drug stores segment held the largest share of the market in 2019. The market for online pharmacies is anticipated to grow at the fastest CAGR during the forecast period.

A few of the major primary and secondary sources referred to while preparing this report on the US home diagnostics for urinary tract infection market are Chronic Kidney Disease (CKD), National Statistics Institute (NSI), Food and Drug Administration (FDA), and Centers for Disease Control and Prevention (CDC).

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the US home diagnostics for urinary tract infection market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the US home diagnostics for urinary tract infection market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.